GSK Sells Irish Plant to Thermo Fisher in $102 Million Deal
GSK Sells Irish Plant to Thermo Fisher in $102 Million Deal
GALWAY, IRELAND--June 17, 2019--Written by Martin Lynch, European News Editor for Industrial Info (Galway, Ireland)--GlaxoSmithKline (NYSE:GSK) (GSK) (Brentford, England) has agreed to sell its pharmaceutical manufacturing plant in Cork, Ireland, to U.S. company Thermo Fisher Scientific Incorporated (NYSE:TMO) (Waltham, Massachusetts) for 90 million euro ($102 million).
Within this article: Details plant sale, products produced, future plans and related GSK plant sell offs
Subscribe Now!(All Fields Required)
Related Articles
Articles related to this company
- GlaxoSmithKline Shutting Irish Skincare Plant
- Power Industry Leads Montana's $1.4 Billion in Projects Under Construction
- GlaxoSmithKline Axing 720 at Belgian Vaccines Hub
- GlaxoSmithKline Sells Rabies and Tick Vaccines in $1.1 Billion Deal
- Thermo Fisher to Acquire Brammer Bio, an Industrial Info Market Brief